Young-Suk Lim
University of Ulsan
H-index: 75
Asia-South Korea
Top articles of Young-Suk Lim
Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territories
Journal of Hepatology
2024/2/1
Safety, pharmacodynamics, and antiviral activity of selgantolimod in viremic patients with chronic hepatitis B virus infection
JHEP Reports
2024/2/1
Outcomes of Liver Resection and Transarterial Chemoembolization in Patients with Multinodular BCLC-A Hepatocellular Carcinoma.
Journal of Liver Cancer
2024/4/3
Longitudinal changes in renal function in patients with chronic hepatitis B on antiviral treatment
Alimentary Pharmacology & Therapeutics
2024/2
Non-linear association of baseline viral load with on-treatment hepatocellular carcinoma risk in chronic hepatitis B
Gut
2024/4/1
Jonggi Choi
H-Index: 13
Young-Suk Lim
H-Index: 48
Advancing Korean nationwide registry for hepatocellular carcinoma: a systematic sampling approach utilizing the Korea Central Cancer Registry database
Journal of Liver Cancer
2024/3/26
Chronic Hepatitis B baseline viral load and on-treatment liver cancer risk: A multinational cohort study of HBeAg-Positive patients
Hepatology
2024/1/24
Gray zone of hepatitis B virus infection
2024/3/1
Young-Suk Lim
H-Index: 48
Cardiovascular risk in chronic hepatitis B patients treated with tenofovir disoproxil fumarate or tenofovir alafenamide
Clinical and Molecular Hepatology
2024/1
CAMP‐B score predicts the risk of hepatocellular carcinoma in patients with chronic hepatitis B after HBsAg seroclearance
Alimentary Pharmacology & Therapeutics
2024/2/29
Atherosclerotic cardiovascular disease risk profile of patients with chronic hepatitis B treated with tenofovir alafenamide or tenofovir disoproxil fumarate for 96 weeks
Alimentary Pharmacology & Therapeutics
2024/1
Introducing W. Ray Kim, MD, Our 2024 AASLD president
Hepatology
2024/1/1
Young-Suk Lim
H-Index: 48
Improving the hepatitis C virus care cascade with the in‐hospital Reflex tEsting ALarm‐C (REAL‐C) model
Liver International
2024/2/20
Prediction of Hepatocellular Carcinoma Development in Korean Patients after Hepatitis C Cure with Direct-Acting Antivirals
Gut and Liver
2024/1/1
Association between statin use and the prognosis of hepatocellular carcinoma after resection: a nationwide cohort study
Eclinicalmedicine
2023/11/1
Evidence for benefits of early treatment initiation for chronic hepatitis B
2023/4/18
Young-Suk Lim
H-Index: 48
Subclassification of advanced-stage hepatocellular carcinoma with macrovascular invasion: combined transarterial chemoembolization and radiotherapy as an alternative first-line …
Journal of Liver Cancer
2023/3
Danbi Lee
H-Index: 6
Young-Suk Lim
H-Index: 48
Jinhong Jung
H-Index: 13
Sang Min Yoon
H-Index: 23
Jonggi Choi
H-Index: 13
Time to consider early treatment for chronic hepatitis B in both children and adults
2023/11
Are the New Nucleos (t) ide Analogs Better than the Old Nucleos (t) ide Analogs?
2023/11/1
Jonggi Choi
H-Index: 13
Young-Suk Lim
H-Index: 48
Hepatocellular carcinoma risk in patients with chronic hepatitis B receiving tenofovir-vs. entecavir-based regimens: Individual patient data meta-analysis
Journal of hepatology
2023/3/1
